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In acute inﬂammation, extracellular ATP activates P2X7
ion channel receptors (P2X7R) on M1 polarized macro-
phages to release pro-inﬂammatory IL-1b through activa-
tion of the caspase-1/nucleotide-binding domain and
leucine-rich repeat receptor containing pyrin domain 3
(NLRP3) inﬂammasome. In contrast, M2 polarized macro-
phages are critical to the resolution of inﬂammation
but neither actions of P2X7R on these macrophages nor
mechanisms by which macrophages switch from pro-in-
ﬂammatory to anti-inﬂammatory phenotypes are known.
Here, we investigated extracellular ATP signalling over a
dynamic macrophage polarity gradient from M1 through
M2 phenotypes. In macrophages polarized towards, but
not at, M2 phenotype, in which intracellular IL-1b remains
high and the inﬂammasome is intact, P2X7R activation
selectively uncouples to the NLRP3-inﬂammasome activa-
tion but not to upstream ion channel activation. In these
intermediate M1/M2 polarized macrophages, extracellular
ATP now acts through its pyrophosphate chains, indepen-
dently of other purine receptors, to inhibit IL-1b release
by other stimuli through two independent mechanisms:
inhibition of ROS production and trapping of the inﬂam-
masome complex through intracellular clustering of actin
ﬁlaments.
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Introduction
Macrophages are critical to both the innate and adaptive
immune response; they must develop and respond to rapid
changes in the microenvironment. Inﬂammation resulting
from pathogens or tissue damage activates resident macro-
phages to initiate or increase production of pro-inﬂammatory
cytokines and other inﬂammatory mediators. However,
macrophages are equally critical in the resolution of inﬂam-
mation by producing anti-inﬂammatory cytokines and che-
mokines and by increased phagocytic activity. On the basis of
Th1/Th2 polarization concepts (Romagnani, 2000), phenoty-
pically polarized macrophages are now generally termed pro-
inﬂammatory M1 or classically activated, and anti-inﬂamma-
tory M2 or alternatively activated (Gordon, 2003; Martinez
et al, 2008). Experimentally, macrophages in vitro are pola-
rized to the M1 state by treatment with IFN-g and inducers of
TNF-a, such as lipopolysaccharide (LPS) or other bacterial
products (Ehrt et al, 2001; Gordon, 2003). M1 macrophages
induce synthesis and upregulation of several pro-inﬂamma-
tory cytokines and chemokines, key among these are TNF-a,
IL-12, IL-6, CCL2 and IL-1b, as well as increased production
of reactive oxygen species (ROS) and nitrogen intermediates
(Gordon, 2003; Martinez et al, 2008). At the other extreme,
macrophages are polarized to the M2 state by stimuli such as
IL-4, IL-13, IL-10 or glucocorticoid hormones (Gordon, 2003;
Martinez et al, 2008). M2 macrophages upregulate scavenger,
mannose and galactose receptors, IL-1 receptor antagonist
and downregulate IL-1b and other pro-inﬂammatory cyto-
kines (Gordon, 2003; Scotton et al, 2005; Martinez et al, 2006,
2008). Very high levels of IL-1b are present in M1 polarized
macrophages because of activation of the NF-kB and MAPK
cascades (Dinarello, 1996) but no IL-1b protein is found in
M2 polarized macrophages (Scotton et al, 2005; Martinez
et al, 2006).
IL-1b processing and release is a tightly regulated process
involving a multiprotein complex, the capase-1 inﬂamma-
some (Martinon et al, 2002). IL-1b is synthesized as a 34kD
precursor protein that is cleaved to its biologically active
17kD form by the protease caspase-1. Inactive caspase-1 is
constitutively present in both M1 and M2 macrophages and is
activated in M1 macrophages by self-cleavage that occurs in
the inﬂammasome complex. Distinct caspase-1 inﬂamma-
somes have been distinguished based on their protein com-
position and means of activation (Mariathasan et al, 2004,
2006; Kanneganti et al, 2006; Martinon et al, 2006). The
nucleotide-binding domain and leucine-rich repeat receptor
containing pyrin domain 3 (NLRP3) inﬂammasome can be
activated by speciﬁc microbial motifs (pathogen-associated
molecular patterns, PAMPs), by Escherichia coli and
Staphylococcus aureus bacteria, by microbial toxins such as
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2114nigericin and maitotoxin (MTX), by uric acid crystals and by
extracellular ATP acting through the ATP-gated plasma mem-
brane ion channel, the P2X7 receptor (P2X7R) (Mariathasan
et al, 2004, 2006; Martinon et al, 2006; Pe ´trilli et al, 2007).
P2X7R activation by ATP released at sites of inﬂammation is
currently the only well-established physiological stimulator
of the NLRP3 inﬂammasome (Ferrari et al, 2006; Mariathasan
et al, 2004, 2006) and, as such, it has become an attractive
target for development of new anti-inﬂammatory drugs
(Pelegrin, 2008). P2X7R gene -deleted mice show anti-inﬂam-
matory phenotypes in models of neuropathic and inﬂamma-
tory pain (Labasi et al, 2002; Chessell et al, 2005) and a
recently developed P2X7R antagonist has shown reduced
joint swelling, tenderness and pain perception in Phase II
clinical trails in patients with rheumatoid arthritis (McInnes
et al, 2007). The P2X7R is a highly unusual ion channel
predominantly expressed in macrophage and microglia; its
activation opens a cationic channel with high permeability to
calcium but it also forms within seconds a larger pore perme-
able to small molecules up to 900Da (Ferrari et al, 2006;
Pelegrin and Surprenant, 2006; Pelegrin et al, 2008). All
downstream sequelae of P2X7R activation except for the
initial cation channel opening require the presence of the
intracellular C-terminus, which is key to the formation of the
P2X7R-multiprotein complex (Ferrari et al, 2006).
This study was prompted by a surprising observation we
made while comparing E. coli and P2X7R-induced activation
of the NLRP3 inﬂammasome and IL-1b release in M1 polar-
ized macrophages. We found that, though E. coli-induced
release of IL-1b remained constant, ATP-evoked IL-1b release
ceased over time in spite of continued high levels of intra-
cellular IL-1b and without decreased functional P2X7Ra s
assayed by upstream ion channel signalling. We found that
unexpected changes in the polarization state of the macro-
phages were causing a P2X7R-speciﬁc uncoupling to the
caspase-1 cascade. We therefore developed an in vitro
model of a likely macrophage polarization gradient from
extreme M1 through to extreme M2 and examined the actions
of different NLRP3-inﬂammasome activators (ATP, E. coli,
MTX and nigericin) over this polarization gradient, as well as
in acute and chronically P2X7R -deleted M1 polarized macro-
phages. This study has identiﬁed a new mechanism by which
extracellular ATP produces physiological inhibition of IL-1b
release that may be key to switching a macrophage from an
inducer of inﬂammation towards its anti-inﬂammatory phe-
notype in the resolution phase of infection or inﬂammation.
Results
Characterization of a dynamic macrophage polarity
gradient
We developed an in vitro polarization protocol designed
to rapidly mimic (over 4–8h) a continuum of signals that
are likely to drive the macrophage from the classic inﬂam-
matory M1 polarity to the anti-inﬂammatory M2 state
(Supplementary Figure S1A available online). Macrophages
from polarities close to M1 (states 1–3) were expanded and
tightly ﬁxed to substrate, formed numerous lamellar pro-
cesses and elongated ﬁlopodia, with diffuse F-actin staining
throughout the cytoplasm but distinctly absent from the
ﬁlopodia (Figure 1A and B). Macrophages from a polarity
close to M2 (state 4) presented less lamellar processes but
remained expanded and tightly ﬁxed to the substrate,
whereas the extreme M2 polarized (alternatively activated)
macrophages had the same morphology as untreated cells
with F-actin being tightly compacted close to the nucleus
(Figure 1A and B). We quantiﬁed these changes in cell
morphology by measuring total surface area over all polari-
zations states and found a gradual progression from state 1
through state 5 (Figure 1C, n¼50–70 cells for each polariza-
tion state). We also conﬁrmed that our protocols did, indeed,
establish a molecular polarization gradient by quantitative
RT–PCR (qPCR) for the classical M1 and M2 genes, TNF-a
and mannose receptor C (MRC-1) (Gordon, 2003; Martinez
et al, 2008); TNF-a gene expression was upregulated by
200-fold in M1 macrophages and this gradually decreased
to near zero in extreme M2 macrophages, whereas MRC-1
gene expression gradually increased over the gradient to
reach a 10-fold upregulation at extreme M2 polarization
(Figure 1D).
P2X7R, but not E. coli, uncouples to inﬂammasome
activation during macrophage polarization
We found that intracellular levels of proIL-1b remained high
in all polarization states (1–4) except, as expected (Gordon,
2003; Martinez et al, 2008), the alternatively activated M2
macrophages (Figure 2A and B). ATP stimulation of P2X7Ri n
M1 activated macrophage and E. coli infection are both well-
characterized pathways known to initiate NLRP3-inﬂamma-
some-dependent release of mature IL-1b (Ferrari et al, 2006;
Mariathasan et al, 2006; Pe ´trilli et al, 2007). However, we
found striking differences in their ability to release IL-1b over
the polarization gradient. In agreement with numerous stu-
dies (Mariathasan et al, 2006; Pelegrin and Surprenant, 2006,
2007; Pe ´trilli et al, 2007), both P2X7R and E. coli stimulation
induced the release of IL-1b from M1 polarized macrophages
but P2X7R-induced release of IL-1b was signiﬁcantly reduced,
or absent, in macrophages of intermediate polarity (states 3,
4; Figure 2A and B). Conversely, E. coli induced signiﬁcantly
greater IL-1b release from these intermediately polarized
macrophages (Figure 2B). Moreover, we observed a similar
uncoupling of P2X7R from IL-1b release during traditional
long-term activation of macrophages with LPS/IFN-g (Arend
et al, 1989). That is, though P2X7Ro rE. coli-induced release
of IL-1b peaked at similar times (5–10h post activation with
either LPS/IFN-g or E. coli), ATP failed to stimulate IL-1b
release subsequently in spite of maintained high levels of
intracellular IL-1b and in contrast to the continued release of
IL-1b by E. coli (Figure 2C). Initially, we hypothesized a
decrease in P2X7R expression was the most likely explanation
for the failure of ATP to stimulate IL-1b release under these
conditions, as clearly the NLRP3-inﬂammasome cascade
known to be activated by E. coli (Pe ´trilli et al, 2007) was
not affected. However, we could not attribute this loss of
P2X7R-mediated release of IL-1b to loss of functional recep-
tors because (i) P2X7R gene expression was actually down-
regulated in M1 macrophages and did not change from states
1 to 3, then increased in states 4 and 5 (Figure 1D); (ii) P2X7R
protein localization remained constant through all polariza-
tion states, in particular the P2X7R protein showed a similar
punctate expression along the cell (Figure 2D); (iii) assays for
upstream signalling of P2X7R (calcium ﬂux and dye-uptake)
(Pelegrin and Surprenant, 2006) did not change over the
polarity gradient (Figure 2E and F). Macrophages obtained
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polarization gradient protocols and served as controls; in
these macrophages no anti-P2X7R antibody staining was
present (data not shown) and no ATP-mediated calcium
ﬂux or dye-uptake occurred in M1 macrophages (Figure 2E
and F) or in M2 macrophages (data not shown).
From positive to negative regulation of IL-1b release
by ATP during macrophage polarization
We next compared inﬂammasome activation proﬁles induced
by ATP and by two toxins, MTX and nigericin, which activate
the NRLP3-inﬂammasome with similar kinetics and mechan-
isms to P2X7R but which are not dependent on P2X7R
(Mariathasan et al, 2006; Pelegrin and Surprenant, 2007)
(Supplementary Figure S1B). IL-1b ELISA assays (which
recognize pro and mature forms of the cytokine) showed
that ATP-induced IL-1b release was reduced by 50–80%
in state 3 intermediate polarized macrophages compared
with M1 polarized cells (Figures 2B and 3A), whereas MTX-
induced IL-1b release was the same in macrophages from
either polarity state or similar to levels of ATP-induced
release from M1 macrophages (Figure 3A). When ATP and
MTX were co-applied, IL-1b release was increased in M1
macrophages to the same extent as in the presence of either
compound alone (Figure 3A). However, co-application of
MTX and ATP to state 3 polarized macrophages resulted in
a 50% reduction of IL-1b release (Figure 3A). Western blots
showed typical release of mature IL-1b from M1 macrophage
in response to ATP, MTX or a combination of MTX and ATP
whereas in state 3 polarized macrophages; mature IL-1b was
detected in response to MTX but not ATP stimulation and co-
application signiﬁcantly decreased release of mature IL-1b
(Supplementary Figure S2A). Strikingly, ATP completely pre-
vented MTX-induced release of IL-1b in M1 polarized macro-
phages after acute blockade of P2X7R with the P2X7R-
selective antagonist, A740003 (Honore et al, 2006) (Figure
3B; Supplementary Figure S2B). ATP similarly inhibited both
MTX and nigericin-induced release of IL-1b from M1 polar-
Figure 1 Functional macrophage plasticity during a polarization gradient. (A, B) Deconvolved images of peritoneal macrophages during
polarization gradient (conditions from 1 to 5, see ‘Materials and methods’) immunostained for mouse macrophage surface marker F4/80 (A) or
labelled with Texas Red-phalloidin to reveal F-actin cytoskeleton (B). Images are representative of three independent experiments; bar¼5mm.
(C) Cellular area measure from peritoneal macrophage during polarization gradient; n¼50–70 cells from three independent experiments.
Horizontal bars represent medians, boxes represent the 25th and 75th percentiles, and vertical bars represent ranges; **Po0.001. (D) Real-time
quantitative RT–PCR for classical M1 (TNF-a) and M2 (mannose receptor C type 1, MRC-1) genes and P2X7R gene during macrophage
polarization gradient. Data are average of triplicate reactions and representative of three independent experiments.
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3C; Supplementary Figure S2C). ATP also inhibited caspase-1
activation (Figure 3C, lower panels) and release of the
inﬂammasome adaptor protein, Apoptosis-associated Speck-
like protein containing a C-terminal caspase-activating
recruiting domain (ASC, Figure 3D) induced by either MTX
or nigericin in M1 polarized P2X7R
 /  macrophages.
Re-introduction of P2X7R into P2X7R
 /  macrophages
through adenoviral delivery reconstituted all features of
ATP-mediated IL-1b release and caspase-1 activation from
M1 polarized macrophages (Supplementary Figure S1D and
E). ATP also failed to induce caspase-1 activation in M2 wild-
type polarized macrophages (Figure 3E), although upstream
signalling through P2X7R (calcium ﬂux, dye-uptake) was not
Figure 2 P2X7R signalling during macrophage polarization gradient. (A) IL-1b and b-actin immunoblot of murine peritoneal macrophage
lysates and supernatants during a polarization gradient from M1 towards M2 (conditions from 1 to 5, see ‘Materials and methods’) in the
presence or absence of 5mM ATP (15min). ATP does not release IL-1b in states 3 and 4 despite high levels of intracellular pro-IL-1b; blots are
representative of three independent experiments. (B, C) ELISA comparing intracellular production and release of IL-1b by mouse peritoneal
macrophages induced by ATP (5mM for 15min) or E. coli (4h) after 4h of polarization to M1 (1, red: LPS and IFN-g), to M2 (5, blue: IL-4) or to
intermediate polarization state (3, green: LPS, IFN-g and IL-4) (B) or after priming for 0–24h with LPS and IFN-g (C); n¼3 independent
cultures for each condition, *P¼0.0483, **P¼0.0014. (D) Deconvolved images of M1 (left panel) or M2 (right panel) polarized peritoneal
macrophages immunostained for F4/80 (red) and for P2X7R (green). Bar, 5mm. (E) Fura2 ﬂuorescence ratio recorded from peritoneal
macrophages isolated from P2X7R
þ/þ or P2X7R
 /  mice polarized to M1, M2 or to an intermediate polarization state. P2X7R receptors were
activated with ATP (1mM, arrow) resulting in typical sustained intracellular calcium increase. Traces are the average of 4–6 independent
cultures and representative of three independent experiments. (F) Kinetics of dye-uptake (ethidium bromide ﬂuorescence) in peritoneal
macrophages isolated from P2X7R
þ/þ or P2X7R
 /  mice polarized to M1, M2 or to an intermediate polarization state in response to 5mM ATP
(arrow), n¼3 independent experiments in each case.
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Taken together, these results show that the inhibitory action
of ATP on these macrophages was due solely to lack of P2X7R
downstream signalling and not to alterations in the NLRP3
inﬂammasome itself. ATP was equally able to inhibit IL-1b
release from the in vitro E. coli model of infection and slow
NLRP3 activation (e.g. Figure 2C; Supplementary Figure S1C)
in M1 polarized macrophages from P2X7R
 /  macrophages
(Figure 3F; Supplementary Figure S2D). This inhibition was
not because of alterations in binding or phagocytosis of the
bacteria by these macrophages in the presence of ATP
(Supplementary Figure S2E).
Negative regulation of IL-1b by ATP is not through
purinoreceptors but is due to pyrophosphate actions
We expected the inhibitory actions of ATP, which occurred
during macrophage polarization from M1 towards M2 states
or which were revealed by acute (selective P2X7R antagonist)
or chronic (P2X7R
 /  macrophage) blockade of P2X7R, to
result from activation of one, or more, purinergic P2X, P2Yor
adenosine receptors. However, results shown in Figure 4,
Supplementary Figure S3A, and E quickly ruled out involve-
ment of any of these receptors in the inhibition of IL-1b
release by ATP. We used M1 polarized macrophages from
P2X7R
 /  mice (Figure 4A–E) or from wild-type mice in the
presence of A740003 (data not shown) and examined the
actions of ATP and other purines on MTX-induced IL-1b
release and caspase-1 activation. First, the ATP concentra-
tion–inhibition curve was 20–100-fold to the right of all
known purine and adenosine receptors except for P2X7R;
indeed, the IC50 value for ATP inhibition of MTX-induced
IL-1b release in P2X7R-depleted macrophage (1.54±0.03mM,
n¼3) was not signiﬁcantly different from the ATP EC50 value
to induce release of IL-1b from wild-type M1 macrophages
Figure 3 Switch from positive to negative regulation of IL-1b release by ATP during macrophage polarization gradient. (A) IL-1b release by
untreated (U), M1 polarized (1: LPS and IFN-g) or intermediate polarized (3: LPS, IFN-g and IL-4) mouse peritoneal macrophages activated for
15min with ATP (5mM), maitotoxin (MTX, 0.2nM) or a combination of ATP and MTX detected by ELISA; n¼3 independent cultures for
ELISA; *P¼0.0121; **P¼0.0013. (B) IL-1b release by M1 polarized mouse peritoneal macrophages induced by 15min of ATP (5mM), MTX
(0.2nM) or a combination of ATP and MTX in the presence of absence of P2X7R antagonist A740003 (10mM, 5min before ATP/MTX) detected
by by immunoblot; blots are representative of three independent experiments. (C) Immunoblots for intracellular IL-1b (top panels), released IL-
1b (middle panels) and released active caspase-1 (p10 subunit, bottom panels) in M1 polarized peritoneal macrophages from P2X7R
þ/þ or
P2X7R
 /  mice stimulated for 15min with ATP (5mM), maitotoxin (MTX, 0.2nM), nigericin (5mM) or a combination of ATP and MTX or ATP
and nigericin; blots are representative of 3–13 independent experiments. (D) Immunoblots for intracellular (top panel) and released (bottom
panel) ASC in M1 polarized peritoneal macrophages from P2X7R
 /  mice stimulated during 15min with ATP (5mM), MTX (0.2nM) or a
combination of ATP and MTX; blots are representative of two independent experiments. (E) Representative traces for caspase-1 activity in M1
or M2 polarized peritoneal macrophages from P2X7R
þ/þ or P2X7R
 /  mice monitored over 30min with the ﬂuorescent probe TMR-
YVADAC(AD) after stimulation with 5mM ATP (arrow). Traces are the average of four independent cultures and are representative of two
independent experiments. (F) P2X7R
 /  M1 polarized peritoneal macrophages were challenged with E. coli for 1h in the absence or presence of
5mM ATP and further incubated for 4h, IL-1b was detected by immunoblot. Blots are representative of three independent experiments.
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ﬁcant inhibition was observed with ATP4ADPbAMP but not
with adenosine (Figure 4B and C). Third, the non-selective
P2X/P2Y inhibitor, suramin and the non-selective P2X
antagonist, PPADS, did not alter the inhibition by ATP of
the nigericin-induced IL-1b in P2X7R-deﬁcient M1 macro-
phages (Supplementary Figure S3A). Most directly, pyropho-
sphate (PPi, Figure 4B–E) and triphosphate (Supplementary
Figure S3C) but not monophosphate (Figure 4D) inhibited
IL-1b release and caspase-1 activation more potently than
ATP, with an IC50 value for PPi of 1.03±0.05mM (n¼3).
The non-hydrolysable bisphosphonate, clodronate (Supple-
mentary Figure S3D), exerted the same inhibition and was
3–5-fold more potent than PPi or ATP, with an IC50 value of
0.43±0.14mM. (Figure 4D and E). Both PPi and clodronate
were effective to inhibit MTX-mediated IL-1b release from
wild-type M1 or M1/M2 intermediate polarized macrophages
but neither inhibited ATP-mediated release from these cells
(Figure 4F). Finally, in HEK cells heterologously expressing
P2X receptors or endogenously expressing P2Y receptors,
neither PPi (5mM) nor clodronate (1mM) alone had any
effect on membrane currents (data not shown) or cytosolic
calcium transients, and nor did they signiﬁcantly alter
the ATP-evoked responses in these cells (Supplementary
Figure S3E).
Clodronate and other bisphosphonates, when encapsu-
lated in liposomes, have been a widely used mechanism to
selectively destroy macrophages (van Rooijen and Sanders,
1994) because macrophages phagocytose the liposomes;
lysosomal phospholipases break down the liposomes and
the resulting free intracellular bisphosphonates initiate apop-
tosis (van Rooijen and Sanders, 1997). Free bisphosphonates
have not been found to accumulate intracellularly (Pennanen
et al, 1995). Nevertheless, we asked whether the application
of clodronate as used in our experiments (up to 30min
applications) may have toxic actions on macrophage that
Figure 4 Negative regulation of IL-1b release by ATP is not because of a purine receptor but to pyrophosphate action. (A–C) Inhibition of MTX
(0.2nM, 15min) induced IL-1b release in M1 polarized peritoneal macrophages from P2X7R
 /  with the indicated concentrations of ATP (A) or
5mM of ATP, ADP, AMP, adenosine (AD) or 0.1 or 5mM of pyrophosphate (PPi) (B, C); immunoblots for intracellular IL-1b (top panels),
released IL-1b (middle panels) or released active caspase-1 (p10 subunit, bottom panels) (A, B) or ELISA for released IL-1b (C).
(D) Immunoblots for intracellular IL-1b (top panel) or released IL-1b (bottom panel) in M1 polarized peritoneal macrophages from
P2X7R
 /  mice stimulated for 15min with MTX (0.2nM) and 5mM of ATP, PPi, inorganic phosphate (Pi) or 1mM clodronate.
(E) Concentration–inhibition curves (solid symbols) of IL-1b release in M1 polarized peritoneal macrophages from P2X7R
 /  mice stimulated
with MTX (0.2nM, 15min) in the presence or absence of different concentrations of ATP (triangles), PPi (circles) or clodronate (squares).
Concentration–response curve (open diamonds) of IL-1b release in M1 polarized peritoneal macrophages from P2X7R
þ/þ mice stimulated
with different concentrations of ATP (15min); n¼3 for each point. (F) Immunoblots for released IL-1b of M1 polarized (1: LPS and IFN-g)o r
intermediate polarized (3: LPS, IFN-g and IL-4) peritoneal macrophages from P2X7R
þ/þ mice stimulated for 15min with MTX (0.2nM) or ATP
(5mM) in the presence or absence of PPi (5mM), clodronate (1mM) or Pi (5mM). n¼3 independent cultures for ELISA and blots are
representative of two to three independent experiments.
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release from all experiments (Supplementary Figure S3B).
No increase in LDH release over basal conditions was ob-
served and in all cases LDH release was o1–3% of total LDH
levels (n¼10–14). This result and the observation that
clodronate alone did not alter intracellular calcium levels
(Supplementary Figure S3E) provide conclusive evidence
against a toxic action of clodronate on these macrophages.
ATP differentially regulates actin polymerization
and inﬂammasome localization during macrophage
polarization gradient
P2X7R and MTX stimulation of M1 polarized macrophages
are associated with rapid and dramatic cytoskeletal re-ar-
rangements (Pfeiffer et al, 2004; Verhoef et al, 2004). We
noticed a striking difference in the actions of ATP on cell
morphology over the M1–M2 polarization gradient, and
therefore asked whether this may be associated with their
actions to inhibit inﬂammasome activation. We examined F-
actin distribution before and 5min after the addition of ATP
(5mM), MTX (0.2nM) or ATP with MTX in M1 polarized
wild type and P2X7R
 /  macrophage, in intermediate state 3
polarized wild-type macrophage and in M1 polarized wild-
type macrophage treated with A740003 (Figure 5A). ATP
induced intense F-actin distribution to only one side of the
cell with extensive ramiﬁcations radiating outward over the
other side; MTX induced an equally intense but uniform F-
actin localization around the entire cell whereas co-applica-
tion produced a randomly radiating network of F-actin
(Figure 5A, panels i–iv; Supplementary Figure S4C). In strik-
ing contrast, ATP induced an intense intracellular clustering
of F-actin in macrophage from intermediate state 3 polariza-
tion as well as from acute and chronic P2X7R-depleted
macrophages (Figure 5A, panels vi, x, xiv), whereas MTX
produced essentially the same F-actin pattern as observed in
M1 polarized wild-type macrophages (Figure 5A, panels vii,
xi, xv). Co-application of ATP and MTX to intermediate state
3 polarized macrophages produced both intracellular F-actin
clustering and radiating F-actin ramiﬁcations (Figure 5A,
panel viii) but co-application to P2X7R-depleted M1 macro-
phages produced the same pattern of intense intracellular
clustering as seen with ATP alone in these macrophages
(Figure 5A, panel xii; Supplementary Figure S4C). PPi and
clodronate induced a similar pattern of intracellular cluster-
ing of F-actin when co-applied with MTX in P2X7R-depleted
macrophages and prevented polymerization of F-actin to the
cell edge (Supplementary Figure S4A and C).
To investigate whether the dynamics of F-actin polymer-
ization were important for the inhibition of inﬂammasome
activation by ATPand PPi, we treated M1 polarized P2X7R
 / 
macrophages with cytochalasin B (CB) to disrupt coordinated
actin cytoskeleton assembly. In agreement with earlier stu-
dies demonstrating that actin-based cytoskeletal pathways
are not directly involved with IL-1b processing and release
(Hornung et al, 2008), we found that CB itself did not induce
IL-1b release nor did it alter MTX-induced release (Figure 5B
and C). However, CB partially reversed (by 30–50%) the
blockade of MTX-induced IL-1b by ATP and PPi (Figure 5B
and C) and prevented intracellular actin clustering
(Supplementary Figure S4B). To gain further insight into
potential mechanisms underlying this earlier undetected in-
volvement of the actin cytoskeleton in NLRP3-inﬂammasome
inhibition, we used a caspase-1-speciﬁc ﬂuorescent probe to
directly identify active caspase-1 within the macrophage. No
active caspase-1 was detected in unstimulated M1 polarized
macrophages from P2X7R
þ/þ (Figure 6A, upper panels) or
P2X7R
 /  mice (Figure 6B, left panel). Stimulation of M1
polarized wild-type macrophages with ATP, or P2X7R
 / 
macrophages with MTX, for 5min led to robust caspase-1
activation in discrete intracellular aggregates that are likely to
represent sites of active inﬂammasome complexes
(Figure 6A, lower panels and B, middle panel). Several of
these active caspase-1 aggregates were observed within the
actin barrier at the edge of the cell (Figure 6A and B, arrows),
suggestive of potential caspase-1/IL-1b release sites. ASC
immunostaining of unstimulated M1 macrophages showed
a uniform cytosolic distribution (Figure 6A, upper middle
panel), whereas ASC formed clusters after ATP stimulation,
many of which co-localized with active caspase-1 (Figure 6A,
arrowheads), conﬁrming their status as an activated inﬂam-
masome complex. However, we also observed many ASC-
only and caspase-1-only aggregates on ATP stimulation,
which may indicate heterogeneous subpopulations of inﬂam-
masome-like complexes (Figure 6A, lower middle panel). We
did not observe any co-localization of active caspase-1 with
the lysosomal marker, cathepsin L (Figure 6A, right panels),
which is in agreement with recent studies showing that the
early release of IL-b does not occur through lysosomal
secretory pathways (Brough and Rothwell, 2007).
Modulation of redox signalling by ATP and PPi during
macrophage polarization
We hypothesized that the inhibition of IL-1b processing and
release by ATP and PPi that was not reversed by treatment
with CB (i.e. the actin-independent inhibition) may result
from reduced ROS production because P2X7R stimulation of
M1 polarized macrophages is known to increase ROS produc-
tion and is associated with NLRP3-inﬂammasome activation
(Dostert et al, 2008; Hewinson et al, 2008) (Supplementary
Figure S4D) and ATP, PPi and bisphosphonates may act
directly or indirectly as oxygen radical scavengers (Serretti
et al, 1993; Kachur et al, 1997; Dombrecht et al, 2006). Both
ATP and MTX induced similar rapid (within 2–3min) in-
creases in ROS production from M1 polarized macrophages
(Figure 7A and E) but in M2 polarized macrophages the
enhanced ROS production was signiﬁcantly delayed (no signi-
ﬁcant increase occurred before 8–10min) and reduced
(Figure 7B and E). MTX similarly increased ROS production
from M1 polarized P2X7R
 /  macrophages (Figure 7C and E),
but MTX-induced ROS production in these cells was pre-
vented by ATP, PPi and clodronate with IC50 values not
signiﬁcantly different from those obtained for inhibition of
IL-1b release (Figure 7C–E), and similar to the ROS scavenger
N-acetyl cystein (Figure 7E). Similarly, PPi and clodronate
were able to block MTX-induced ROS production in M1 wild-
type macrophages, but fail to block P2X7R-induced ROS
production from the same cells (Figure 7E), this could explain
the underlying mechanism for the differential activation of
the inﬂammasome by ATP and MTX observed between M1
and intermediate polarized macorphages (Figures 3A and
4F). Finally, MTX stimulation of ROS production and its
inhibition by ATP and PPi were not signiﬁcantly altered by
treatment with cytochalasin B (Figure 7F).
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The concept of monocytes/macrophages existing in function-
ally distinct phenotypes from pro- to anti-inﬂammatory states
has been well established by detailed studies on M1 (classi-
cally activated) and M2 (alternatively activated) macro-
phages (Gordon, 2003; Scotton et al, 2005; Martinez et al,
2006, 2008). However, only recently it has begun to be
appreciated that macrophages are able to reversibly and
dynamically switch from one activation state to the other
(Stout and Suttles, 2004; Porcheray et al, 2005; Gratchev et al,
2006). Here, we have used a polarization gradient of cyto-
kines and endotoxin to rapidly generate a 5-stage in vitro
model of macrophage polarization from M1 through M2. In
Figure 5 ATP differentially regulates actin polymerization during macrophage polarity gradient. (A) Deconvolved images of F-actin
cytoskeleton labelled with Texas Red-phalloidin in peritoneal macrophages isolated from P2X7R
þ/þ or P2X7R
 /  mice after differentiation
to M1 or to intermediate state 3 polarization state, unstimulated or stimulated for 5min with ATP (5mM), MTX (0.2nM) or a combination of
ATP and MTX, in the presence or absence of A740003 (10mM, 5min before ATP). Bar, 5mm. Images are representative of three independent
experiments. (B, C) M1 polarized peritoneal macrophages isolated from P2X7R
 /  mice were treated with cytochalasin B (CB; 2.5mg/ml, 5min
before MTX) and stimulated for 15min with MTX (0.2nM) or a combination of MTX and ATP (5mM) or PPi (3mM), and IL-1b release was
detected by immunoblots (B) or by ELISA (C); n¼3 independent cultures for ELISA and representative of two independent experiments, blots
are representative of two independent experiments.
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except ATP continued to activate the inﬂammasome and
release IL-1b. In intermediate polarization states, as well as
in P2X7R-deﬁcient macrophages, ATP no longer signalled to
caspase-1 activation; rather, ATP now acted through its
diphosphate and/or triphosphate chains independently of
any other purine receptor to block activation of the NLRP3
inﬂammasome by other activators. This was accomplished by
two independent mechanisms: a direct reduction in ROS
production and a rapid trapping of the inﬂammasome com-
plex because of dramatic intracellular clustering of the actin
cytoskeleton. Our results suggest this uncoupling of P2X7R
from caspase-1 activation may prove to be a key trigger in the
switch from a pro-inﬂammatory macrophage towards its
alternative functions in the resolution of inﬂammation.
Moreover, we have identiﬁed a new cellular mechanism by
which the inﬂammasome can be inhibited through physiolo-
gical alterations in the cytoskeleton.
The characteristics of P2X7R-induced release of IL-1b from
M1 activated macrophages are well established: intracellular
pro-caspase-1 is rapidly cleaved and mature IL-1b, as well as
caspase-1 and other inﬂammasome components (e.g. ASC)
are released within minutes (2–10min) after receptor stimu-
lation (Mariathasan et al, 2004, 2006; Ferrari et al, 2006;
Pelegrin and Surprenant, 2006). In this study we compared
these established properties of P2X7R activation in M1 macro-
phages with those of macrophages exposed to a gradient of
M1–M2 activation. We have focused on the intermediate
polarization state (state 3) in wild-type mouse macrophages
because it provides us with a representation of a macrophage
on the cusp between M1 and M2 phenotypes. In state 3,
intermediate polarized macrophages intracellular levels of
pro-IL-1b were similar to M1 macrophages, and P2X7R
mRNA levels, protein levels and protein localization patterns
showed no clear differences from M1 macrophages. Initial
upstream signalling events, which occur in the seconds to
Figure 6 Cellular dynamics and localization of the inﬂammasome. (A) Deconvolved images of P2X7R
þ/þ M1 polarized peritoneal
macrophages stained for active caspase-1 (green) and F-actin cytoskeleton (red, left panels), ASC (red, middle panels) or cathepsin L (red,
right panels), before (top panels) or after (bottom panels) stimulation with ATP (5mM, 5min). Arrows show active caspase-1 crossing actin
barrier and presumably being released; co-localization of active caspase-1 with ASC (arrowheads) indicating active inﬂammasomes; note no
colocalization between active casapse-1 and lysosomal marker cathepsin L. (B) M1 polarized peritoneal macrophages isolated from P2X7R
 / 
mice labelled for active caspase-1 (green) and F-actin cytoskeleton with Texas Red-phalloidin (red) stimulated for 5min with MTX (0.2nM)
alone or in combination with ATP (5mM). Bar, 5mm. Images are representative of two independent experiments.
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able ion channel (calcium, sodium inﬂux/potassium efﬂux)
and the P2X7R-pannexin-1-associated large pore (dye-uptake)
(Pelegrin and Surprenant, 2006, 2007), were also the same as
in M1 macrophages. E. coli, MTX or nigericin-induced IL-1b
release was the same as, or signiﬁcantly increased, in these
macrophages but ATP-induced release and caspase-1 activa-
tion were decreased by 50–80% because of an uncoupling of
P2X7R signalling to ROS production and caspase-1 activation.
Most strikingly, when ATP was co-applied with any of these
other NLRP3-inﬂammasome activators, caspase-1 activation
and IL-1b release were virtually abolished. Taken together,
these results suggest that a speciﬁc uncoupling of P2X7R from
the downstream caspase-1 cascade was occurring in inter-
mediate state polarized macrophages without changes in
receptor activation per se or its initial ion channel/dye-uptake
pore activation.
We initially supposed that such an uncoupling of P2X7R
from the inﬂammasome allowed ATP to now has a negative
action on IL-1b release induced by other stimuli through one,
or more, other purine receptor. However, we found that ATP
blocked E. coli, MTX and nigericin-induced caspase-1 activa-
tion and IL-1b release in these macrophages by an action that
did not involve other purine or adenosine receptors. This is a
valid conclusion because agonist proﬁles did not correspond
to any of these receptors; generic P2X and P2Y antagonists
Figure 7 ATP modulation of ROS production during macrophage polarization. (A–C) ROS production was monitored over 20min with the
ﬂuorescent probe H2HFF-BSA in M1 (A, C) or M2 (B) macrophages from P2X7R
þ/þ (A, B) or P2X7R
 /  (C) mice stimulated with ATP (5mM),
MTX (0.2nM) or a combination of ATP and MTX; traces are the average of three to four independent cultures and are representative of three
independent experiments. (D) Concentration–inhibition curves of ROS production induced by MTX (0.2nM, 20min) in the presence or absence
of different concentrations of ATP (squares), PPi (circles) or clodronate (triangles) in P2X7R
 /  M1 macrophages; n¼3 for each point.
(E) Average of three different experiments for ROS production at 20min by M1 or M2 polarized macrophages from P2X7R
þ/þ (open bars)
or P2X7R
 /  (grey bars) mice stimulated as in (A–C), in the presence or absence of PPi (5mM), clodronate (1mM) or N-acetyl cystein (NAC,
20mM); *P¼0.0005; **P¼0.0003; ***P¼0.0002. (F) P2X7R
 /  M1 macrophages were treated with cytochalasin B (CB; 2.5mg/ml, 5min
before MTX) and ROS production was induced by 20min incubation at 371C with 0.2nM of MTX in the absence or presence of 5mM of ATP or
3mM of PPi; n¼4 independent cultures and representative of two independent experiments.
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observed in P2X7R-deﬁcient macrophages and, unequivo-
cally, because pyrophosphates (tri and di, but not mono,
phosphates) as well as the non-hydrolysable bisphosphonate,
clodronate, inhibited caspase-1 activation and IL-1b
with potency order of clodronate4triphosphateEdiphos-
phate4ATPbADP, suggesting that the diphosphate group
resident in ADP could partially block inﬂammasome without
involvement of PPi metabolism. It is tempting to speculate
that ecto-nucleotidases may play a critical role in the
switch of a macrophage from an M1 to an M2 state during
inﬂammatory resolution but future studies of expression
levels and activities of the large family of these molecules
(Zimmermann, 2000) are likely to provide insight into
whether speciﬁc ecto-nucleotidases may have a critical func-
tion in the switch of a macrophage from an M1 to an M2 state
during inﬂammatory resolution. In any event, our results
show that when P2X7Rs are fully functional, that is when
they couple to inﬂammasome activation in M1 macrophages,
the actions of ATP are solely stimulatory on IL-1b release.
That is, neither PPi nor clodronate inhibited ATP-mediated
IL-b release from M1 macrophages nor even from state 3
intermediate polarized macrophages in which the P2X7R-
speciﬁc IL-1b release was still present although at a much
reduced level, while they effectively blocked MTX- and
E. coli-induced inﬂammasome activation. These results
further support our suggestion that a speciﬁc uncoupling of
otherwise functional P2X7Rs from the caspase-1 cascade is
the key event in the switch of ATP from inducing (through
P2X7R) to inhibiting (through PPP/PPi) IL-1b release
(Figure 8). Recent pharmacological studies have shown that
ROS production in M1 macrophages is a critical step for
activation of the NLRP3 inﬂammasome in response to ATP,
toxins or crystals (Dostert et al, 2008; Hewinson et al, 2008)
and P2X7R activation recruits to the plasma membrane and
activates NADPH oxidase complex (Hewinson et al, 2008).
However, a recent study has not found genetic support for the
role of ROS in NLRP3-inﬂammasome activation (Hornung
et al, 2008). Here, we found that in M2 macrophages P2X7R
activation induces only a weak ROS response that may be
owing to a speciﬁc uncoupling from recruitment of the
NADPH oxidase complex without alterations in P2X7R up-
stream signalling, correlating with the low level of NLRP3
activation and IL-1b release found in intermediate polarized
macrophages after ATP/P2X7R stimulation.
By imaging individual macrophages using a caspase-1-
speciﬁc ﬂuorescent probe and co-labelling for actin or ASC
as an integral component in the inﬂammasome complex, we
found that P2X7R activation in M1 macrophages not only
induced rapid actin cytoskeletal rearrangements along a
spatial gradient but also rapid formation of active caspase-
1/ASC aggregates, which we interpret as likely sites of
functionally active inﬂammasomes. Several of these aggre-
gates tightly abutted the external surface of actin ﬁlaments
outlining the plasma membrane, suggesting potential sites of
release. In striking contrast, ATP applied to P2X7R-depleted
M1 macrophages, or to state 3 intermediate polarized macro-
phages, produced a rapid and intense intracellular clustering
of actin ﬁlaments. A similar pattern of intracellular clustering
of actin was observed when ATP, pyrophosphate or clodro-
nate were co-applied with MTX to these macrophages
with little or no activated caspase-1 ﬂuorescence signals.
Cytochalasin B blocked this intracellular aggregation of
actin and reversed by 30–50% the inhibition of release
observed in the presence of MTX plus ATP or pyrophosphate.
Thus, we have identiﬁed intracellular clustering of actin
ﬁlaments as a novel mechanism for inhibition of inﬂamma-
some activation (Figure 8).
This study has direct and immediate clinical and physio-
logical relevance. Clodronate and other bisphosphonates
have been in clinical use for decades, primarily for the treat-
ment of osteoarthritis and other inﬂammatory or metastatic
bone diseases (Maksymowych, 2002; Russell et al, 2008).
Their primary mechanism of action is generally considered to
be one of effective chelation of calcium crystal deposits on
bone mineral surfaces, resulting in inhibition of osteoclast
Figure 8 Proposed model for inﬂammasome regulation by extracelluar ATP during macrophage polarization gradient. In M1 polarized
macrophages ATP acting through P2X7R is linked with an increase production of ROS, actin polymerization to the edge of the cell, activation of
the NLRP3 inﬂammasome/caspase-1 and rapid release of the pro-inﬂammatory mature IL-1b cytokine. However, during the resolving phase of
the inﬂammation M1 macrophages switch their phenotype towards M2 and now P2X7R uncouples to both ROS production and the NLRP3-
inﬂammasome/caspase-1 pathway although it remains functional in terms of its ion channel activity. Under these conditions (intermediate
state 3) the PPi group of ATP acts to further inhibit ROS and induces an intracellular clustering of actin that blocks the inﬂammasome/
activation of caspase-1 and the release of mature IL-1b to enhance the resolving phase of the inﬂammation. The PPi may result from ATP
metabolism by ecto-nucleotidases or may act by phosphate chains remaining attached to the nucleotide molecule.
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Conversely, several studies have provided evidence that
they may also exert an anti-inﬂammatory action in bone
and immune cells independent of their calcium chelation
properties (Pennanen et al, 1995; Maksymowych, 2002).
The pyrophosphate actions to inhibit IL-1b release identiﬁed
in this study may underlie these anti-inﬂammatory actions of
bisphosphonates. A novel, highly selective and potent P2X7R
antagonist, AZ9056, is currently in clinical trials for rheuma-
toid arthritis (McInnes et al, 2007). Studies to date point to
the primary mechanism of action of such P2X7R antagonists
as being through inhibition of IL-1b release (Labasi et al,
2002; Pelegrin, 2008). Our present work continues to support
this conclusion but now raises the possibility that a second-
ary effect of P2X7R inhibition is to further inhibit IL-1b release
evoked by other activators by allowing pyrophosphates—
either through extracellular ATP metabolism or directly
through the phosphate chains of the intact nucleotides—to
directly prevent inﬂammasome activation by other bacterial
or endogenous inﬂammatory mediators through inhibition of
ROS production and by intracellular trapping of the inﬂam-
masome complex. Clinical investigations into the potential of
co-therapy with P2X7R antagonists and bisphosphonates in
chronic inﬂammatory diseases may prove fruitful.
Materials and methods
Cells and reagents
Key reagents and their sources: E. coli LPS O55:B5, ATP, ADP, AMP,
adenosine, PPi, triphosphates, N-acetyl cystein, a-tocopherol,
nigericin (Sigma); MTX (Alexis); clodronate, caspase-1 substrate
(N
a-5-tetramethylrhodaminyl-YVADAC(S-acrylodan)-OH), cytocha-
lasin B (Calbiochem); IFN-g, IL-4 and IL-1b (PeproTech). E. coli
DH5a strain, DAPI, phalloidin-Texas Red and OxyBURST H2HFF-
BSA (Invitrogen). Abs for ELISAs and cathepsin L were from R&D,
for P2X7R from Alamone Laboratories, caspase-1 p10 rabbit
polyclonal and b-actin from Santa Cruz Biotechnology, ASC from
Alexis, IL-1b mAb from the Biological Resources Branch, National
Cancer Institute. All HRP-conjugated secondary Abs were from
DAKO Cytomation. A740003 P2X7R antagonist was synthesized by
ArtMolecule.
C57BL/6J (P2X7R
þ/þ) and P2X7R-deﬁcient (P2X7R
 / ) mice in
C57BL/6J background were used (Chessell et al, 2005). All
experiments were performed under the Animals (Scientiﬁc Proce-
dures) Act 1986. Peritoneal macrophages were obtained as
described earlier (Pelegrin and Surprenant, 2006). Brieﬂy, the
peritoneal cavity was gently lavaged with phosphate-buffered saline
(PBS, Invitrogen). The recovered buffer from two to three mice was
pooled, cells were collected by centrifugation (250g, 5min) and
plated on coverslips, or in 12-well plates at a density of 10
6 cell/
well, or in 24-well plates at a density of 0.5 10
6 cell/well, or in
96-well plates black with clear bottom at a density of 1.5 10
6 cell/
well in RPMI 1640 media (Invitrogen) supplemented with 10% fetal
calf serum (Invitrogen), 100 units/ml penicillin and 100mg/ml
streptomycin (Invitrogen). The macrophages were allowed to
adhere overnight (371C, 5% CO2) and washed with fresh medium
to remove unattached cells before use.
Cell culture and stimulation
Macrophages plated on 12-well plates were primed with fresh
medium supplemented with different stimuli to obtain a gradient of
polarity phenotypes (Supplementary Figure S1A). For clarity, the
different polarity phenotypes have been represented in the ﬁgures
and in the text with a number, a colour and a shape. LPS (1mg/ml)
and IFN-g (20ng/ml) for 4h were used to differentiate to M1
phenotype (polarity state 1, square, red). IL-4 (20ng/ml) was used
for 4h to differentiate to M2 phenotype (polarity state 5, round,
blue). A combination of LPS/IFN-g/IL-4 for 4h was used to
differentiate an M1/M2 intermediate macrophage polarization
phenotype (polarity state 3, diamond, green). To study the polarity
changes and to achieve intermediate polarity states, cells were
stimulated ﬁrst for 4h with IL-4, washed and then stimulated for
further 4h with LPS/IFN-g (polarity state 2, star, pink); or
stimulated ﬁrst for 4h with LPS/IFN-g, washed and then stimulated
for further 4h with IL-4 (polarity state 4, triangle, yellow).
Macrophages were stimulated for 15min with agonists as described
earlier (Pelegrin and Surprenant, 2007). Alternatively, to examine
the blocking of IL-1b release, macrophages were incubated with
0.01–5mM of ATP, PPi, triphosphate or clodronate or with 5mM of
ADP, AMP, AD or Pi or with 20mM N-acetyl cystein or 10mM a-
tocopherol together with MTX (0.2nM). E. coli stimulation was
performed as described earlier (Pe ´trilli et al, 2007). Macrophages
were stimulated either with LPS/IFN-g (polarity state 1), IL-4
(polarity state 5) or with a combination of LPS/IFN-g/IL-4 (polarity
state 3) for 2h, washed in Optimem and challenged with E. coli for
1h in the presence or absence of ATP (0.1–5mM); the cells were
then washed and placed in Optimem complemented with 100 units/
ml penicillin and 100mg/ml streptomycin for further 4h.
Western blot, ELISAs, intracellular calcium and dye-uptake
assays
Detailed methods used for western blot analysis, ELISAs, Fura2
calcium imaging and ethidium bromide uptake have been described
earlier (Pelegrin and Surprenant, 2006). Blots were analysed by
densitometry measurements using NIH ImageJ software (http://
rsb.info.nih.gov/ij/).
Immunocytochemistry and microscopy
Macrophages stimulated on coverslips were washed twice with
PBS, ﬁxed with 4% formaldehyde for 30min at room temperature,
and then washed three times with PBS. Cells were blocked with 3%
bovine serum albumin and permeabilized with 0.1% triton X-100 in
PBS for 30min at room temperature before incubating with rat anti-
mouse F4/80 antibody (1:500), rabbit anti-P2X7R (1:500), rabbit
anti-ASC (1:250) or with goat anti-cathepsin L (1:250) for 18–20h at
41C or for 2h at room temperature. Cells were washed and
incubated with appropriate FITC-, TRITC- or Cy3-conjugated
secondary antibody (1:200) for 2h at room temperature, then
rinsed in PBS and incubated for 15min with 300nM of DAPI and in
some experiments with phalloidin-Texas Red (1:100). To stain for
active caspase-1, macrophages were activated with 5mM ATP or
0.2nM MTX for 5min at 371C, washed and incubated with the
ﬂuorochrome inhibitor of caspase-1, green ﬂuorescent peptide
5-carboxyﬂuorescein-Tyr-Val-Ala-Asp-ﬂuoromethyl ketone (FAM-
YVAD-fmk), according to the manufacturer’s recommendations
(Immunochemistry Technologies). Cells were ﬁxed with 4%
formaldehyde, blocked, permeabilized and co-stained for F-actin
(phalloidin-Texas Red), ASC or cathepsin L. All coverslips were
mounted on slides with ProLong Gold Antifade Reagent (Invitro-
gen). Images were acquired at room temperature on a Delta Vision
RT (Applied Precision) restoration microscope using a 60x/1.42
Plan Apo or 100x/1.40 Uplan Apo objectives and the 360/475nm,
490/528nm and 555/617nm ﬁlter sets (Chroma 86000v2). The
images were collected using a Coolsnap HQ (Photometrics) camera
with a Z optical spacing of 0.2mm. Raw images were then
deconvolved using Softworx software and maximum intensity
projections of these deconvolved images are shown in the results.
ImageJ software (http://rsb.info.nih.gov/ij/) was used to quantify
images.
Quantitative reverse transcriptase–PCR analysis
Detailed methods used for qRT–PCR have been described earlier
(Pelegrin and Surprenant, 2006). Speciﬁc primers were purchased
from Qiagen (QuantiTech Primer Assays), for each primer set the
efﬁciency was 495% and a single product was seen on melt curve
analysis. Relative expression levels were calculated using the 2
 DDCt
method normalizing to GAPDH expression levels for each treatment
and the fold increase in expression was relative to the smallest
expression level.
Caspase-1 activity and reactive oxygen species measurement
Macrophages were plated in a 96-well plate black with clear bottom
and primed to reach different polarity states. For casapse-1 activity,
cells were pre-incubated with 37.5mM TMR-YVADAC(AD) at 371C
for 1h and washed twice with E-total. Fluorescence was recorded
using FlexStation 3 over 30min at 1min intervals at 380nm for
excitation and 525nm for the emission. ATP (5mM) was added into
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For ROS generation, polarized macrophages were washed with PBS
and incubated with ATP, clodronate, PPi (0.1–5mM) or N-acetyl
cystein (20mM) and/or MTX (0.2nM) in the presence of 10mg/ml
H2HFF-BSA and ﬂuorescence emmision by the oxidation of H2HFF-
BSA was recorded by FlexStation 3 over 60min at 1min intervals at
492nm for excitation and 520nm for the emission.
Statistical analysis
Average results are expressed as the mean±s.e.m. from the number
of assays indicated (from at least three separate cultures). Data were
analysed by an unpaired two-tailed Student’s t-test to determine
difference between groups using Prism and Instat (GraphPad)
software.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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